The store will not work correctly when cookies are disabled.
(2S)-2-Amino-3-methylsulfonyl-N-[3-(trifluoromethoxy)phenyl]propanamide
ID: ALA4776312
PubChem CID: 135388266
Max Phase: Preclinical
Molecular Formula: C11H13F3N2O4S
Molecular Weight: 326.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)C[C@@H](N)C(=O)Nc1cccc(OC(F)(F)F)c1
Standard InChI: InChI=1S/C11H13F3N2O4S/c1-21(18,19)6-9(15)10(17)16-7-3-2-4-8(5-7)20-11(12,13)14/h2-5,9H,6,15H2,1H3,(H,16,17)/t9-/m1/s1
Standard InChI Key: PYZPDUSQAFMYLL-SECBINFHSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
7.6162 -6.8162 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2079 -7.5328 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0326 -7.5282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9192 -5.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9180 -5.8895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6329 -6.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3492 -5.8890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3464 -5.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6310 -4.6494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2033 -6.3013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4892 -5.8884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7745 -6.3002 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.4899 -5.0634 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.7707 -5.4747 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.0643 -6.3003 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7780 -5.8867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4931 -6.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7768 -5.0618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4945 -7.1231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2070 -5.8845 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2108 -8.3593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
10 11 1 0
11 12 1 0
11 13 1 0
11 14 1 0
7 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
17 20 1 6
19 2 1 0
2 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.30 | Molecular Weight (Monoisotopic): 326.0548 | AlogP: 0.90 | #Rotatable Bonds: 5 |
Polar Surface Area: 98.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.92 | CX Basic pKa: 6.51 | CX LogP: 0.61 | CX LogD: 0.56 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -1.44 |
References
1. Yamada Y,Takashima H,Walmsley DL,Ushiyama F,Matsuda Y,Kanazawa H,Yamaguchi-Sasaki T,Tanaka-Yamamoto N,Yamagishi J,Kurimoto-Tsuruta R,Ogata Y,Ohtake N,Angove H,Baker L,Harris R,Macias A,Robertson A,Surgenor A,Watanabe H,Nakano K,Mima M,Iwamoto K,Okada A,Takata I,Hitaka K,Tanaka A,Fujita K,Sugiyama H,Hubbard RE. (2020) Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity., 63 (23): [PMID:33210531] [10.1021/acs.jmedchem.0c01215] |